Literature DB >> 10771012

alpha7 receptor-selective agonists and modes of alpha7 receptor activation.

R L Papke1, E Meyer, T Nutter, V V Uteshev.   

Abstract

The alpha7-selective agonists 3-(2, 4-dimethoxybenzylidene)-anabaseine (GTS-21), also known as DMXB, and 3-(4-hydroxy,2-methoxybenzylidene)anabaseine (4OH-GTS-21) produce a variety of behavioral and cytoprotective effects that may be related to the activation of either large transient currents at high concentrations or small sustained currents at lower agonist concentrations. We are using acutely dissociated hypothalamic neurons, which express a central nervous system (CNS) alpha7-type receptor, to test a model for the concentration-dependent desensitization of alpha7-mediated responses. Our results confirm that 4OH-GTS-21 is a potent activator of neuronal alpha7 nicotinic-acetylcholine receptor. The rapid application of agonist leads to a brief period of maximal receptor-activation followed by desensitization. Rise rates, decay rates, and the degree to which current was desensitized were all concentration-dependent. Following the initial peak response to a 300-microM 4OH-GTS-21 application, current is reduced to baseline values within about 100 ms. Application of 30 microM 4OH-GTS-21 produced both a transient peak current and a sustained current that decayed only slowly after the removal of agonist. In the case of a 300-microM 4OH-GTS-21 application, after agonist was removed, we saw a rebound response up to the level of the 30-microM sustained current. The data, therefore, suggest that a sufficient level of agonist occupation can be retained on the receptor to promote activation for up to several hundred milliseconds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771012     DOI: 10.1016/s0014-2999(00)00009-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  45 in total

1.  Increased nicotinic receptor desensitization in hypoglossal motor neurons following chronic developmental nicotine exposure.

Authors:  Jason Q Pilarski; Hilary E Wakefield; Andrew J Fuglevand; Richard B Levine; Ralph F Fregosi
Journal:  J Neurophysiol       Date:  2011-10-19       Impact factor: 2.714

2.  Fast synaptic transmission in the goldfish CNS mediated by multiple nicotinic receptors.

Authors:  Charlotte L Grove; Theresa M Szabo; J Michael McIntosh; Samantha C Do; Robert F Waldeck; Donald S Faber
Journal:  J Physiol       Date:  2010-11-29       Impact factor: 5.182

3.  Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.

Authors:  Roger L Papke; Caryn Trocmé-Thibierge; Daniela Guendisch; Shehd Abdullah Abbas Al Rubaiy; Stephen A Bloom
Journal:  J Pharmacol Exp Ther       Date:  2011-02-01       Impact factor: 4.030

Review 4.  Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors.

Authors:  Bruce E McKay; Andon N Placzek; John A Dani
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

5.  Number and locations of agonist binding sites required to activate homomeric Cys-loop receptors.

Authors:  Diego Rayes; María José De Rosa; Steven M Sine; Cecilia Bouzat
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

Review 6.  Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.

Authors:  G Sharma; S Vijayaraghavan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 7.  Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits.

Authors:  Huibert D Mansvelder; Marjolijn Mertz; Lorna W Role
Journal:  Semin Cell Dev Biol       Date:  2009-01-22       Impact factor: 7.727

8.  Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Mol Pharmacol       Date:  2011-09-01       Impact factor: 4.436

Review 9.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

Review 10.  High throughput electrophysiology with Xenopus oocytes.

Authors:  Roger L Papke; Cathy Smith-Maxwell
Journal:  Comb Chem High Throughput Screen       Date:  2009-01       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.